The size of the nebulizer market in the United States is forecasted to grow at a CAGR of 7.42% from 2023 to 2028.
Factors such as excessive cigarette and alcohol consumption, poor diet, lack of physical activity, and alarming obesity rates are also expected to contribute to a rise in the prevalence of respiratory disorders in the United States, boosting the nebulizer market in the U.S. during the forecast period. Compact nebulizers that are available for home usage and technical advancements in nebulizers that minimize noise and increase functionality are increasing their use in home healthcare. Insurance providers choose such machines because they want to save money while also delivering high-quality healthcare. All these factors contribute to the growth of the U.S. nebulizer industry. Another important factor driving global demand for nebulizers is raising emission levels due to increased adoption of private vehicles and industrial expansion.
Increasing demand for effective inhaled drugs, healthcare costs, and longer hospital stays have resulted in a change in inpatient treatment to home environments, increasing the use of breathable medical devices for home healthcare. Nebulizers are instruments that convert liquid drugs into aerosols for use in the lungs (liquid particles in a gas). The drug is transformed into a mist that can be inhaled immediately by the user. The increasing prevalence of chronic respiratory disorders and rapid technological advancements is driving the use of nebulizers. For new nebulizer pharmaceutical drug production, mesh nebulizers have been the first option. Mesh nebulizers are expected to become more common in the future. Because of their low residual volumes and precise lung delivery, these treatments are portable, convenient, and fast.
The main restriction for the growth of the U.S. nebulizer market is dispersion and wastage of the drug during delivery to the respiratory tract, which is a spraying technique. Over the forecast period, the demand is expected to be hampered by limited reimbursement policies in developed countries and the higher cost of these instruments based on mesh and ultrasonic techniques.
The U.S. Nebulizer Market Research Report has been segmented and sub-segmented into the following categories.
Geographically, one of the main factors for the increase in market demand in the United States is the rise in pollution rates and the increasing number of cases related to respiratory problems, including neonatal treatment. The growing geriatric population in the United States, the high prevalence of target diseases, and the need to reduce healthcare costs are all considered to be major driving forces for home healthcare products. Furthermore, post-financial-crisis healthcare cost containment issues in the United States have compelled the government to implement new strategies to reduce hospital stays. This boosted homecare facilities, which in turn built a favorable atmosphere for the nebulizer market to grow. Patients seeking more portable nebulizer devices that can be transferred easily in times of need for patients who have asthma and other airway disorders are searching for more portable nebulizer devices because the population in the region follows a fast-paced lifestyle. The COVID-19 pandemic has sparked a surge in the use of nebulizers in the United States. As a result of increased national health spending, the country will grow.
KEY MARKET PLAYERS:
Some of the major companies operating in the U.S. nebulizer market profiled in this report are Briggs Healthcare, Besco Medical, Ca-Mi, De Vilbiss Healthcare, Feellife Health, Flyp, Invacare, Omron, Philips Respironics, and Pari Medical.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]